Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort Study.

Skriver C, Dehlendorff C, Borre M, Brasso K, Larsen SB, Dalton SO, Nørgaard M, Pottegård A, Hallas J, Sørensen HT, Friis S.

Ann Intern Med. 2019 Mar 5. doi: 10.7326/M17-3085. [Epub ahead of print]

PMID:
30831581
2.

Postdiagnosis Statin Use and Mortality in Danish Patients With Prostate Cancer.

Larsen SB, Dehlendorff C, Skriver C, Dalton SO, Jespersen CG, Borre M, Brasso K, Nørgaard M, Johansen C, Sørensen HT, Hallas J, Friis S.

J Clin Oncol. 2017 Oct 10;35(29):3290-3297. doi: 10.1200/JCO.2016.71.8981. Epub 2017 Aug 14.

PMID:
28806117
3.

Aspirin use and ovarian cancer mortality in a Danish nationwide cohort study.

Verdoodt F, Kjaer SK, Dehlendorff C, Friis S.

Br J Cancer. 2018 Feb 20;118(4):611-615. doi: 10.1038/bjc.2017.449. Epub 2018 Jan 9.

4.

Daily aspirin use and prostate cancer-specific mortality in a large cohort of men with nonmetastatic prostate cancer.

Jacobs EJ, Newton CC, Stevens VL, Campbell PT, Freedland SJ, Gapstur SM.

J Clin Oncol. 2014 Nov 20;32(33):3716-22. doi: 10.1200/JCO.2013.54.8875. Epub 2014 Oct 20.

PMID:
25332245
5.

Non-aspirin NSAID use and ovarian cancer mortality.

Verdoodt F, Dehlendorff C, Friis S, Kjaer SK.

Gynecol Oncol. 2018 Aug;150(2):331-337. doi: 10.1016/j.ygyno.2018.06.018. Epub 2018 Jun 28.

PMID:
29960709
6.

A cohort study investigating aspirin use and survival in men with prostate cancer.

Flahavan EM, Bennett K, Sharp L, Barron TI.

Ann Oncol. 2014 Jan;25(1):154-9. doi: 10.1093/annonc/mdt428.

PMID:
24356627
7.

Statin use and mortality among endometrial cancer patients: a Danish nationwide cohort study.

Sperling CD, Verdoodt F, Kjaer Hansen M, Dehlendorff C, Friis S, Kjaer SK.

Int J Cancer. 2018 Dec 1;143(11):2668-2676. doi: 10.1002/ijc.31625. Epub 2018 Oct 9.

PMID:
29923185
8.

Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians' Health Study.

Downer MK, Allard CB, Preston MA, Gaziano JM, Stampfer MJ, Mucci LA, Batista JL.

Eur Urol. 2017 Nov;72(5):821-827. doi: 10.1016/j.eururo.2017.01.044. Epub 2017 Feb 8.

PMID:
28189429
9.

Low-dose aspirin use and risk of contralateral breast cancer: a Danish nationwide cohort study.

Bens A, Friis S, Dehlendorff C, Jensen MB, Ejlertsen B, Kroman N, Cronin-Fenton D, Mellemkjær L.

Prev Med. 2018 Nov;116:186-193. doi: 10.1016/j.ypmed.2018.09.015. Epub 2018 Sep 24.

PMID:
30261243
10.

Low-dose aspirin use and survival in breast cancer patients: A nationwide cohort study.

Mc Menamin ÚC, Cardwell CR, Hughes CM, Murray LJ.

Cancer Epidemiol. 2017 Apr;47:20-27. doi: 10.1016/j.canep.2016.12.008. Epub 2017 Jan 12.

PMID:
28088656
12.

Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric Cancer.

Spence AD, Busby J, Johnston BT, Baron JA, Hughes CM, Coleman HG, Cardwell CR.

Gastroenterology. 2018 Mar;154(4):849-860.e1. doi: 10.1053/j.gastro.2017.10.044. Epub 2017 Nov 6.

PMID:
29122547
13.

Low-dose aspirin and survival in men with prostate cancer: a study using the UK Clinical Practice Research Datalink.

Cardwell CR, Flahavan EM, Hughes CM, Coleman HG, O'Sullivan JM, Powe DG, Murray LJ.

Cancer Causes Control. 2014 Jan;25(1):33-43. doi: 10.1007/s10552-013-0306-x. Epub 2013 Dec 6.

PMID:
24310109
14.

Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study.

Skriver C, Dehlendorff C, Borre M, Brasso K, Sørensen HT, Hallas J, Larsen SB, Tjønneland A, Friis S.

Cancer Causes Control. 2016 Sep;27(9):1067-79. doi: 10.1007/s10552-016-0785-7. Epub 2016 Aug 9.

PMID:
27503490
15.

Low-dose aspirin use and the risk of ovarian cancer in Denmark.

Baandrup L, Kjaer SK, Olsen JH, Dehlendorff C, Friis S.

Ann Oncol. 2015 Apr;26(4):787-92. doi: 10.1093/annonc/mdu578. Epub 2014 Dec 23.

PMID:
25538177
16.

Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk: A Population-Based, Case-Control Study.

Friis S, Riis AH, Erichsen R, Baron JA, Sørensen HT.

Ann Intern Med. 2015 Sep 1;163(5):347-55. doi: 10.7326/M15-0039.

PMID:
26302241
17.

Do Aspirin and Other NSAIDs Confer a Survival Benefit in Men Diagnosed with Prostate Cancer? A Pooled Analysis of NIH-AARP and PLCO Cohorts.

Zhou CK, Daugherty SE, Liao LM, Freedman ND, Abnet CC, Pfeiffer R, Cook MB.

Cancer Prev Res (Phila). 2017 Jul;10(7):410-420. doi: 10.1158/1940-6207.CAPR-17-0033. Epub 2017 May 15.

18.

Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.

Grytli HH, Fagerland MW, Fosså SD, Taskén KA.

Eur Urol. 2014 Mar;65(3):635-41. doi: 10.1016/j.eururo.2013.01.007. Epub 2013 Jan 14.

PMID:
23351721
19.

The effect of aspirin and nonsteroidal anti-inflammatory drug use after diagnosis on survival of oesophageal cancer patients.

van Staalduinen J, Frouws M, Reimers M, Bastiaannet E, van Herk-Sukel MP, Lemmens V, de Steur WO, Hartgrink HH, van de Velde CJ, Liefers GJ.

Br J Cancer. 2016 Apr 26;114(9):1053-9. doi: 10.1038/bjc.2016.65. Epub 2016 Apr 7.

20.

The use of aspirin and the risk of mortality in patients with prostate cancer.

Assayag J, Pollak MN, Azoulay L.

J Urol. 2015 Apr;193(4):1220-5. doi: 10.1016/j.juro.2014.11.018. Epub 2014 Nov 14.

PMID:
25463991

Supplemental Content

Support Center